Suppr超能文献

印度国家结核病控制规划修订版下新的肺结核患者治疗失败的风险因素

Risk factors for new pulmonary tuberculosis patients failing treatment under the Revised National Tuberculosis Control Programme, India.

作者信息

Singla R, Srinath D, Gupta S, Visalakshi P, Khalid U K, Singla N, Gupta U A, Bharty S K, Behera D

机构信息

Department of Tuberculosis and Chest Diseases, Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.

出版信息

Int J Tuberc Lung Dis. 2009 Apr;13(4):521-6.

Abstract

SETTING

Tertiary level tuberculosis (TB) institute in Delhi, India.

OBJECTIVE

To study the risk factors for new pulmonary TB (PTB) patients failing treatment.

DESIGN

Prospective case-control study. The profile of new PTB patients failing treatment (i.e., sputum smear-positive at 5 months of treatment) and responders under the Revised National Tuberculosis Control Programme (RNTCP) were compared and risk factors associated with treatment failure were analysed.

RESULTS

A total of 42 treatment failure cases and 76 controls were enrolled in the study. The presence of cavity on chest X-ray (CXR), sputum acid-fast bacilli (AFB) smear positivity at 2 months of treatment and the number of interruptions in treatment were independently associated with failures. Among failure patients at 5 months, 17 (40.5%) had negative sputum culture for Mycobacterium tuberculosis, and only six (14.3%) had multidrug-resistant TB (MDR-TB). When put on retreatment, patients with smear-positive, culture-negative sputum had cure rates of 88.2% compared to 28.6% among culture-positive patients.

CONCLUSIONS

The presence of cavity on CXR, sputum smear positivity at 2 months of treatment and the number of interruptions of treatment are risk factors for failure. Among failures based on smear examination, the prevalence of MDR-TB is low and many patients have negative cultures for M. tuberculosis. Smear positivity at the end of treatment may not be a reliable indicator of treatment failure.

摘要

背景

印度新德里的三级结核病研究所。

目的

研究初治肺结核(PTB)患者治疗失败的危险因素。

设计

前瞻性病例对照研究。比较了在修订的国家结核病控制规划(RNTCP)下治疗失败的初治PTB患者(即治疗5个月时痰涂片阳性)和治疗有效的患者,并分析了与治疗失败相关的危险因素。

结果

共纳入42例治疗失败病例和76例对照。胸部X线片(CXR)显示有空洞、治疗2个月时痰抗酸杆菌(AFB)涂片阳性以及治疗中断次数与治疗失败独立相关。在5个月时治疗失败的患者中,17例(40.5%)结核分枝杆菌痰培养阴性,仅6例(14.3%)为耐多药结核病(MDR-TB)。再次治疗时,涂片阳性、培养阴性的患者治愈率为88.2%,而培养阳性患者的治愈率为28.6%。

结论

CXR显示有空洞、治疗2个月时痰涂片阳性以及治疗中断次数是治疗失败的危险因素。在基于涂片检查的治疗失败患者中,MDR-TB的患病率较低,许多患者结核分枝杆菌培养阴性。治疗结束时涂片阳性可能不是治疗失败的可靠指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验